8 November 2017 | Geneva −− The World Health Organization (WHO) and the Mundo Sano Foundation are working to make an essential antiparasitic medicine for treatment of Chagas disease widely accessible to children. Treatment with […]
On August 29th, the U.S. Food and Drug Administration (FDA) approved Chemo Research’s New Drug Application (NDA) for benznidazole. This is the first drug ever approved by the FDA to treat Chagas disease.
Benznidazole is an […]
Cycling 750km from Madrid to Lisboa to give visibility to the Chagas
Today August 28 begins in Madrid, for the third year in a row, an activity promoted by Chemo Group called Reto Chagas, which consists […]
The Executive Committee of the Pan American Health Organization (PAHO) began its 160th annual meeting on Monday, June 26 at its headquarters in Washington DC.
The delegations of PAHO member countries, such as Argentina, Brazil, Chile, […]
On 16 June 2017, the Mundo Sano Foundation and the European & Developing Countries Clinical Trials Partnership (EDCTP) created a partnership to leverage research funding for neglected infectious diseases (NIDs). They agreed that Mundo Sano […]
The 19th of May 2017, Dr. Marina Gold carried out a presentation “Humanitarian Assistance on site and in the diaspora and Chagas in endemic and non-endemic countries. The case of Santiago del Estero/Argentina and Geneva” during […]